Healthcare / Medical - Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

LON/0QNO stock hub

LON/0QNO has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0QNOis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

31.8B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0QNO

In the news

Latest news · LON/0QNO

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E26.4

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE10.5

P25 -54.2P50 2.1P75 13.7

ROIC9.5

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0QNO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

208

Groups with data

Currency

CHF

Showing 208 of 208 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Switzerland
Country code	UK
Employees	20,000
Employees Change	1,056%
Employees Change Percent	5.57
Enterprise value	CHF 35.6B
Exchange	London Stock Exchange
Financial currency	CHF
First seen	2026-05-10
Industry	Medical - Diagnostics & Research
Isin	CH0013841017
Last refreshed	2026-05-10
Market cap	CHF 31.8B
Price	CHF 485
Price currency	CHF
Rev Per Employee	305,979.76x
Sector	Healthcare
Sic	2800
Symbol	lon/0QNO
Website	https://www.lonza.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-0.81%
EV Earnings	-138.27x
EV/EBIT	26.98x
EV/EBITDA	17.32x
EV/FCF	-230.45x
EV/Sales	5.78x
FCF yield	-0.49%
Forward P/E	26.36x
P/B ratio	4.27x
P/S ratio	5.2x
PE Ratio10 Y	41.91x
PE Ratio3 Y	59.64x
PE Ratio5 Y	52.68x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	21.39%
EBITDA Margin	32.72%
Gross margin	35.97%
Gross Profit	CHF 2.2B
Gross Profit Growth	-6%
Gross Profit Growth3 Y	-0.81%
Gross Profit Growth5 Y	-0.38%
Net Income	CHF -257.7M
Net Income Growth Quarters	3%
Net Income Growth Years	0%
Pretax Margin	16.86%
Profit Margin	-4.21%
Profit Per Employee	CHF -12,884
ROA	4.64
Roa5y	4.39
ROCE	9.78
ROE	10.48
Roe5y	8.67
ROIC	9.49
Roic5y	9.32

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	13.22%
Cagr1y	-15.66%
Cagr3y	-5.07%
Cagr5y	-2.82%
Div CAGR10	7.46%
Div CAGR3	13.48%
Div CAGR5	9.65%
EPS Growth Years	0
OCF Growth	-17.37%
OCF Growth10 Y	-0.21%
OCF Growth3 Y	-7.4%
OCF Growth5 Y	1.85%
Revenue Growth	-1.57x
Revenue Growth Years	0x
Revenue Growth3 Y	-0.88x
Revenue Growth5 Y	0.82x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CHF 0.35
Assets	CHF 16.8B
Cash	CHF 673.7M
Current Assets	CHF 6.5B
Current Liabilities	CHF 3.4B
Debt	CHF 4.4B
Debt EBITDA	CHF 2.15
Debt Equity	CHF 0.59
Debt FCF	CHF -28.36
Equity	CHF 7.5B
Interest Coverage	8.32
Liabilities	CHF 9.3B
Long Term Assets	CHF 10.3B
Long Term Liabilities	CHF 5.9B
Net Cash	CHF -3.7B
Net Cash By Market Cap	CHF -11.65
Net Debt EBITDA	CHF 1.85
Net Debt Equity	CHF 0.5
Tangible Book Value	CHF 5.3B
Tangible Book Value Per Share	CHF 75.46
WACC	8.05

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.89
Inventory Turnover	2.45
Net Working Capital	CHF 2.7B
Quick ratio	0.62
Working Capital	CHF 3B
Working Capital Turnover	CHF 2.41

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.51%
Dividend Growth	1.99%
Dividend Growth Years	7%
Dividend per share	CHF 3.58
Dividend Years	13
Dividend Yield	0.74%
Ex Div Date	2025-05-13
Last Dividend	CHF 3.58
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	246.15%
1Y total return	-15.65%
200-day SMA	535.2
3Y total return	-14.46%
50-day SMA	500.7
50-day SMA vs 200-day SMA	50under200
5Y total return	-13.34%
All Time High	785.4
All Time High Change	-38.24%
All Time High Date	2021-09-07
All Time Low	81.5
All Time Low Change	495.18%
All Time Low Date	2014-04-15
ATR	14.03
Beta	0.82
Ch YTD	-9.79
High	491.1
High52	594.8
High52 Date	2025-07-23
High52ch	-18.45%
Low	472.9
Low52	455.1
Low52 Date	2026-03-23
Low52ch	6.59%
Ma50ch	-3.13%
Price vs 200-day SMA	-9.37%
RSI	42.23
RSI Monthly	42.39
RSI Weekly	41.8
Sharpe ratio	-0.97x
Sortino ratio	-1.07
Total Return	3.25%
Tr YTD	-9.79
Tr1m	-3.78%
Tr1w	1.17%
Tr3m	-6.07%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CHF 1.3B
Operating Income Growth	11.54
Operating Income Growth3 Y	1.22
Operating Income Growth5 Y	0.69
Operating margin	21.39

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	69,809,979%
Net Borrowing	-428,616,015.1
Shares Insiders	0.05%
Shares Institutions	41.12%
Shares Yo Y	-2.51%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CHF -208M
Average Volume	85,161.85x
Bv Per Share	106.2
CAPEX	CHF -1.2B
Ch10y	198.9
Ch1m	-3.78
Ch1w	1.17
Ch1y	-16.24
Ch3m	-6.07
Ch3y	-16.21
Ch5y	-16
Ch6m	-8.55
Change	-0.3%
Change From Open	-0.74
Close	486.5
Days Gap	0.45
Depreciation Amortization	698,625,222.8
Dollar Volume	55,072,714.5
Earnings Date	2026-07-22
EBIT	CHF 1.3B
EBITDA	CHF 2B
EPS	CHF -3.68
F Score	5
FCF	CHF -154.6M
FCF EV Yield	-0.43x
Financing CF	-708,377,578
Fiscal Year End	December
Founded	1,897
Goodwill	1,850,412,752.3
Income Tax	CHF 179.9M
Investing CF	-672,771,297
Is Primary Listing	0
Last Earnings Date	2026-04-01
Last Report Date	2025-12-31
Ma150	527.9
Ma150ch	-8.11%
Ma20	501.7
Ma20ch	-3.32%
Net CF	-305,464,405
Next Earnings Date	2026-07-22
Open	488.7
P OCF Ratio	29.4
Payment Date	2025-05-15
Position In Range	66.86
Ppne	7,839,707,905.9
Price Date	2026-05-08
Price EBITDA	CHF 15.9
Ptbv Ratio	6.04
Relative Volume	1.4x
Revenue	6,119,595,186x
SBC By Revenue	0.87x
Share Based Comp	53,409,421
Tax By Revenue	2.94x
Tax Rate	17.44%
Tr6m	-8.55%
Volume	113,536
Z Score	3.91

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0QNO dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.7%

$3.58 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+9.7%

7 consecutive years of growth

Total shareholder yield

+3.3%

Next ex-dividend date: 2025-05-13

Performance

LON/0QNO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0QNO?

Insider, institutional, and short-interest positioning.

Institutional ownership

+41.1%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-2.5%

Negative means the company is buying back shares.

Technical

LON/0QNO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.2

Neutral momentum band

Price vs 200-day MA

-9.4%

50/200-day relationship not available

Beta (5Y)

0.82

Moves roughly with the market

Sharpe ratio

-0.97

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0QNO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0QNO stock rating?

lon/0QNO is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0QNO analysis?

The full report lives at /stocks/lon/0QNO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0QNO?

The latest report frames lon/0QNO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0QNO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.